SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-018610
Filing Date
2020-07-07
Accepted
2020-07-07 13:05:50
Documents
1
Period of Report
2020-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11229
  Complete submission text file 0000899243-20-018610.txt   12733
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL SUITE 325 CHARLOTTE NC 28277
Business Address
Clemens Kevan (Reporting) CIK: 0001316737 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 201015775